• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎行肝移植术后,原位胆总管残端新发胆管癌。

De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis.

机构信息

University of California, Los Angeles, Department of Medicine, Los Angeles, CA, USA.

出版信息

Ann Hepatol. 2009 Oct-Dec;8(4):379-83.

PMID:20009140
Abstract

Primary sclerosing cholangitis (PSC) is a chronic, progressive, inflammatory and obstructive disease of the intra- and extra-hepatic bile ducts of unknown etiology. Currently, orthotopic liver transplantation (OLT) is the only definitive treatment for PSC-related end-stage liver disease. However, PSC has been known to recur in the grafted liver. Roux-en-Y hepaticojejunostomy is more commonly performed than choledochocholedochostomy for PSC, although choledochocholedochostomy has been found to be safe and efficacious for PSC if the distal common bile duct is uninvolved at the time of OLT. Our case is unique in that it describes a patient who developed de-novo cholangiocarcinoma in the remnant portion of the native common bile duct six years after OLT with choledochocholedochostomy for PSC-associated end-stage liver disease without having PSC recurrence. In conclusion, our case report indicates that choledochocholedochostomy may not be desirable in PSC due to an increased risk of developing cholangiocarcinoma in the native common bile duct. This risk exists as well with a Roux-en-Y hepaticojejunostomy in the remaining intra-duodenal and intra-pancreatic biliary epithelium, although in theory to a lesser extent. Therefore, the risk of developing cholangiocarcinoma in the recipient common bile duct can only be completely eliminated by performing a Whipple procedure at the time of OLT.

摘要

原发性硬化性胆管炎(PSC)是一种原因不明的肝内外胆管的慢性、进行性、炎症性和阻塞性疾病。目前,原位肝移植(OLT)是 PSC 相关终末期肝病的唯一确定性治疗方法。然而,PSC 已知会在移植肝中复发。与 PSC 相比,Roux-en-Y 肝肠吻合术更为常见,尽管如果在 OLT 时远端胆总管未受累,胆管空肠吻合术对于 PSC 是安全有效的。我们的病例很独特,它描述了一名患者在 OLT 后六年,因 PSC 相关终末期肝病而行胆管空肠吻合术,在没有 PSC 复发的情况下,在残留的原发性胆总管中出现新发胆管癌。总之,我们的病例报告表明,由于原发性胆总管中发生胆管癌的风险增加,胆管空肠吻合术在 PSC 中可能并不理想。在剩余的十二指肠内和胰内胆管上皮中,虽然理论上程度较轻,但 Roux-en-Y 肝肠吻合术也存在这种风险。因此,只有在 OLT 时行胰十二指肠切除术才能完全消除受体胆总管发生胆管癌的风险。

相似文献

1
De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis.原发性硬化性胆管炎行肝移植术后,原位胆总管残端新发胆管癌。
Ann Hepatol. 2009 Oct-Dec;8(4):379-83.
2
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
3
Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.肝切除-惠普尔整块切除联合原位肝移植治疗早期肝门部胆管癌放疗后的长期无瘤生存
Liver Transpl. 2008 Mar;14(3):279-86. doi: 10.1002/lt.21287.
4
Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy.与肝空肠吻合术相比,原发性硬化性胆管炎肝移植中的胆管对胆管重建与更少的胆道并发症相关。
Liver Transpl. 2014 Apr;20(4):457-63. doi: 10.1002/lt.23827.
5
Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者肝移植前胆管癌筛查的趋势
Digestion. 2014;89(2):165-73. doi: 10.1159/000357445. Epub 2014 Feb 22.
6
Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.原发性硬化性胆管炎患者胆囊肿瘤的患病率及危险因素:化生-发育异常-癌序列的证据
Am J Surg Pathol. 2007 Jun;31(6):907-13. doi: 10.1097/01.pas.0000213435.99492.8a.
7
[Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma].[肝切除-惠普尔整块切除术联合原位肝移植治疗早期肝门部胆管癌放疗后的长期无瘤生存]
Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1155-61.
8
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.肝移植后复发性原发性硬化性胆管炎:一项磁共振胆管造影研究及预测因素分析
Liver Transpl. 2005 Nov;11(11):1361-9. doi: 10.1002/lt.20444.
9
Meta-analysis of Duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎肝移植术后胆管对胆管与 Roux-en-Y 胆管重建的荟萃分析。
Transpl Int. 2015 Apr;28(4):485-91. doi: 10.1111/tri.12513. Epub 2015 Jan 21.
10
Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.金属支架、磁铁还是肝移植:原发性硬化性胆管炎伴狭窄的治疗选择。
Hepatol Int. 2018 Nov;12(6):510-519. doi: 10.1007/s12072-018-9906-6. Epub 2018 Nov 14.

引用本文的文献

1
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者胆管癌的发病率及治疗结局综述。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1336-1366. doi: 10.4251/wjgo.v13.i10.1336.
2
Biliary endoscopy in the management of primary sclerosing cholangitis and its complications.胆道内镜在原发性硬化性胆管炎及其并发症管理中的应用
Liver Res. 2019 Jun;3(2):106-117. doi: 10.1016/j.livres.2019.03.004. Epub 2019 Apr 3.
3
Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
原发性硬化性胆管炎的癌症风险:流行病学、预防和监测策略。
World J Gastroenterol. 2019 Feb 14;25(6):659-671. doi: 10.3748/wjg.v25.i6.659.
4
Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.原发性硬化性胆管炎,第2部分:癌症风险、预防与监测
Gastroenterol Hepatol (N Y). 2018 Jul;14(7):427-432.
5
Primary sclerosing cholangitis: A review and update.原发性硬化性胆管炎:综述与更新
Liver Res. 2017 Dec;1(4):221-230. doi: 10.1016/j.livres.2017.12.002.
6
Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.对从原发性硬化性胆管炎患者肝脏中分离出的培养胆管细胞的特性分析。
Lab Invest. 2014 Oct;94(10):1126-33. doi: 10.1038/labinvest.2014.94. Epub 2014 Jul 21.
7
Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.原发性硬化性胆管炎与微生物群:关于病因发病机制及新兴疗法的当前认识与展望
Scand J Gastroenterol. 2014 Aug;49(8):901-8. doi: 10.3109/00365521.2014.913189. Epub 2014 Jul 3.
8
Role of the microbiota and antibiotics in primary sclerosing cholangitis.肠道微生物群和抗生素在原发性硬化性胆管炎中的作用。
Biomed Res Int. 2013;2013:389537. doi: 10.1155/2013/389537. Epub 2013 Oct 22.